Live Evaluations
PA and NP Management of Chronic Hand Eczema: Hope on the Horizon: PANP24
About
PA and NP Management of Chronic Hand Eczema: Hope on the Horizon
This activity is supported by an educational grant from LEO Pharma.
Learning Objectives
At the completion of this activity, participants should be better able to:
Describe the diverse clinical presentation of chronic hand eczema
Define the role of new and emerging topical therapies for the management of chronic hand eczema
Identify treatment plans for patients who would benefit from new and emerging topical therapies based on patient characteristics, preferences, and treatment goals
Intended Audience
Faculty
Raj Chovatiya, MD, PhD, MSCI
Clinical Associate Professor, Rosalind Franklin University Chicago Medical School, Founder and Director, Center for Medical Dermatology and Immunology Research
Chicago, IL
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Consultant: AbbVie, Arcutis, Arena, Argenx, Beiersdorf, Bristol Myers Squibb, Dermavant, Eli Lilly and Company, EPI Health, Incyte, LEO Pharma, L’Oréal, National Eczema Association, Pfizer Inc., Regeneron, Sanofi, and UCB
Speakers’ Bureau or Honoraria: AbbVie, Arcutis, Dermavant, Eli Lilly and Company, Incyte, LEO Pharma, Pfizer Inc., Regeneron, Sanofi, and UCB
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.